GeoVax Labs, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that GeoVax Labs, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($6.32M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($5.37M) | Jul 28, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($5.37M) | Nov 13, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($5.36M) | Jul 28, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($5.36M) | May 1, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($5.36M) | Nov 13, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($5.82M) | Nov 13, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($5.06M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($5.06M) | Jul 28, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($5.85M) | Jul 28, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($5.85M) | Nov 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($5.85M) | May 1, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($8.41M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($5.93M) | Aug 6, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($5.93M) | Nov 12, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($4.04M) | Aug 6, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($4.04M) | May 14, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($4.04M) | Nov 12, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($3.97M) | Nov 8, 2023 |
| Q3 | 2023 | Jun 30, 2022 | ($2.24M) | Nov 8, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($6.37M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($5.42M) | Jul 28, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($5.41M) | May 1, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($5.85M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($5.06M) | Jul 28, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($5.88M) | May 1, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($8.60M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($6.18M) | Aug 6, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($4.27M) | May 14, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($3.97M) | Nov 8, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($2.24M) | Aug 9, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($2.43M) | May 4, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($1.95M) | Nov 9, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($1.49M) | Aug 3, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($1.56M) | Apr 27, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($436.3K) | Nov 12, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($448.1K) | Aug 11, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($595.3K) | May 6, 2021 |
| Q3 | 2020 | Sep 30, 2019 | ($425.9K) | Nov 5, 2020 |
| Q2 | 2020 | Jun 30, 2019 | ($653.9K) | Aug 10, 2020 |